Retroperitoneal Tumor Registry

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The RETROR registry aims to build a clinical database of patients with retroperitoneal tumors by systematically gathering demographic data, comorbidities, imaging findings, perioperative details, pathology results, adjuvant therapy, surgical complications, recurrence, metastasis, and survival. It will summarize clinical features, evaluate surgical outcomes, and explore factors that may influence prognosis. Enrollment requires informed consent from participants. The study is observational and does not assign interventions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with preoperative imaging or pathological diagnosis of retroperitoneal tumors, with no restriction on age and gender.

Exclusion Criteria:

* Patients with psychiatric or neurological disorders who cannot express their will properly.
* Patients who are unable to understand the study protocol and refuse to participate or sign the informed consent form.

Where it's running

• The First Hospital of Jilin University
  Changchun, Jilin, China Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating the Role of Vascular Surgeons in Surgery for Retroperitoneal Tumors

  This study is trying to see if having vascular surgeons help with surgery for retroperitoneal tumors can lead to better outcomes for patients.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Italia · NCT06803251

• Polatuzumab Vedotin plus Rituximab with Reduced-dose chemo for frail seniors with DLBCL

  This trial tests whether a gentler, first-line treatment (Polatuzumab Vedotin with Rituximab and reduced-dose chemo) helps older, frail patients with DLBCL stay disease-free longer.

  Recruiting Phase 4 The First Hospital of Jilin University · Changchun, Jilin · NCT07908888

• Vision-language AI helps emergency CT readers spot thoraco-abdominal problems

  This trial tests whether a self-developed AI model can help radiologists find acute thoraco-abdominal emergencies on CT scans more accurately than standard reading in adult emergency patients.

  Recruiting The First Hospital of Jilin University · Changchun, Jilin · NCT07899931

• Tegileridine for pain after bariatric surgery

  This phase 3 trial tests tegileridine vs standard opioid medicine to see if it provides good pain relief after bariatric surgery while considering sleep apnea status.

  Recruiting Phase 3 The First Hospital of Jilin University · Changchun, Jilin · NCT07844512

• Modular robotic surgery to remove GEJ cancers at Siewert II/III

  This trial tests a modular robotic system to perform minimally invasive removal of Siewert type II/III gastroesophageal junction cancers in adults.

  Recruiting The First Hospital of Jilin University · Changchun, Jilin · NCT07790809

• Removing enlarged cardiophrenic lymph nodes during surgery for advanced ovarian cancer

  This will try removing enlarged cardiophrenic lymph nodes during surgery in women with advanced ovarian, fallopian tube, or primary peritoneal cancer to see if it delays cancer coming back and is safe.

  Recruiting The First Hospital of Jilin University · Changchun, Jilin · NCT07572409

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.